title: [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
authors.forename: B
authors.initials: B
authors.lastname: Coppere
authors.forename: G
authors.initials: G
authors.lastname: Granade
authors.forename: M H
authors.initials: MH
authors.lastname: Girard-Madoux
authors.forename: J P
authors.initials: JP
authors.lastname: Claudel
authors.forename: G
authors.initials: G
authors.lastname: Kruszynski
authors.forename: J
authors.initials: J
authors.lastname: Porte
authors.forename: M
authors.initials: M
authors.lastname: Gayral
authors.forename: J
authors.initials: J
authors.lastname: Ninet
mesh_terms: D016255:Anistreplase / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol; D004620:Embolism, Fat / Q000139:chemically induced*; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D016255:Anistreplase; D002784:Cholesterol
vernacular_title: Embols de cristaux de cholestérol après thrombolyse intraveineuse par anistreplase pour suspicion d'infarctus myocardique.